Guidelines for Conducting Food Challenges in a Medical Setting
Food challenges must be conducted in a medical facility with onsite medical supervision, appropriate medications, and equipment to manage potential allergic reactions, including anaphylaxis. 1
Pre-Challenge Preparation
Patient Selection and Risk Assessment
- Evaluate patient's history of previous reactions, especially history of anaphylaxis
- Patients with recent life-threatening reactions, particularly if multiple episodes, should avoid intentional challenges 1
- Higher risk patients include those with:
- History of food-induced anaphylaxis
- Persistent asthma
- History of reacting to trace food contaminants 1
Medication Discontinuation
Before the challenge, discontinue medications that may interfere with results:
- Oral antihistamines: 3-10 days before (varies by medication)
- Cetirizine: 5-7 days
- Diphenhydramine: 3 days
- Oral/IM/IV steroids: 3 days-2 weeks
- Leukotriene antagonists: 24 hours
- Short-acting bronchodilators: 8 hours 1
Dietary Preparation
- Eliminate suspected foods from diet for 2-8 weeks prior to testing
- Patient should fast for at least 4 hours before challenge for anticipated immediate reactions
- For delayed reactions, fasting may be extended up to 12 hours 1
Challenge Protocol
Challenge Types
- Open Challenge: Food is given in its natural form, both patient and provider know what is being tested
- Single-Blind Challenge: Patient doesn't know if receiving test food or placebo
- Double-Blind, Placebo-Controlled Food Challenge (DBPCFC): Neither patient nor provider knows if test food or placebo is being given; gold standard for diagnosis 1
Dosing Protocol
- Begin with doses lower than those expected to trigger a reaction
- Starting dose recommendations:
- 10 mg of allergenic food for standard protocol
- Lower doses (3 mg protein) for high-risk patients 1
- Dose progression:
Challenge Materials and Environment
- Conduct in location where food can be heated and measured
- Use clean disposable plates, cups, and utensils to prevent cross-contamination
- Have liquid and solid forms of challenge food available
- Create child-friendly environment for pediatric challenges 1
Monitoring and Safety
Observation Parameters
- Monitor vital signs, skin examination, respiratory assessment
- Document gastrointestinal symptoms and subjective complaints
- Observe for objective signs of allergic reaction 3
Emergency Preparedness
- Have emergency medications readily available, including:
- Ensure staff is trained in anaphylaxis management
- Be prepared to repeat epinephrine every 5-10 minutes as necessary 4
Challenge Interpretation
Positive Challenge
- Stop challenge at first objective sign of allergic reaction
- Document symptoms and treatments required
- Observe patient for several hours after resolution of symptoms
- Provide clear instructions on continued allergen avoidance 1
Negative Challenge
- After negative blinded challenge, conduct open feeding with natural form of food
- Observe for additional 2 hours after open feeding
- Instruct patient to reintroduce food into diet gradually
- Tolerance is confirmed when food is regularly consumed without reactions 1
Special Considerations
Multiple Food Challenges
- May test multiple foods on same day with 2-hour breaks between challenges
- For cross-reactive foods (tree nuts, fish, shellfish), consider mixed challenges
- After negative challenge, reintroduce foods one at a time at home 1
Delayed Reactions
- For non-IgE-mediated reactions, longer observation periods may be necessary
- May require subsequent feedings with regular portions over days/weeks
- Patients may record symptoms while continuing feedings at home 1
Common Pitfalls to Avoid
- Inadequate emergency preparedness
- Inappropriate patient selection
- Failure to discontinue interfering medications
- Using severity of challenge reaction to predict future reaction severity
- Insufficient observation period after challenge
- Inadequate patient education about post-challenge care 3
Food challenges remain the gold standard for diagnosing food allergies, as they provide definitive evidence of clinical reactivity beyond what skin or blood testing can offer 3, 5.